APP and Down syndrome: These results suggest a more general paradigm for neurological and neuropsychiatric sporadic brain disease, whereby known genes from rare, familial cases—such as APP for Down syndrome or familial AD—are somatically and mosaically altered by GM to produce common forms of disease.